Granules India reports income from operations at Rs 1,030 crores up 29 per cent
YoY, EBITDA at Rs 193 crores, EBITDA margin at 19 per cent; PAT at Rs 111 crores
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin releases Q4FY22 results
Basis the long-term outlook, the company's Board has recommended a dividend of 200 per cent
Centrient Pharma announces 100 per cent compliance for clean manufacturing of its oral antibiotic…
The standard covers both Centrient’s sites and its suppliers’ sites
CDSCO approves Boehringer Ingelheim’s Jardiance for treating heart failure
It's the first treatment for heart failure with preserved ejection fraction (HFpEF) in India
Health OK launches gummies for children
The gummies are formulated to cater to the specific needs of growing children
CCI approves Serum Institute Life Sciences-Biocon Biologics deal
Once the deal is complete, Serum Institute Life Sciences will have about 15 per cent stake in Biocon Biologics, according to the…
Top 20 global biopharma companies by MCAP experience favourable Q12022
Majority of the top 20 global biopharma companies reported a 2.1 per cent increase in aggregate MCAP, from $3.4 trillion on 31st…
China Junshi’s potential COVID drug shows promise in small trial
The drug, called VV116, is a derivative of Gilead Sciences's COVID drug Remdesivir and was approved for use in moderate-to-severe…
Estrogen treatment linked with reduced COVID mortality: Study
The research, published in the journal 'Family Practice,' analysed the association between hormone replacement therapy or combined…
Sun Pharma plans to launch oral lipid-lowering drug Brillo in India
Brillo is a first-in-class drug which has a new mechanism of action compared to the currently available lipid-lowering agents